-
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) had also recommended the internasal vaccine clinical trials during the last meeting.
-
New Delhi: Hyderabad-based Bharat Biotech on Wednesday claimed that its COVID vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus. In a statement, Bharat Biotech said, “Results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose of Covaxin (BBV152) six months after getting a primary […]
-
Hyderabad: Bharat Biotech, the maker of Covid-19 vaccine Covaxin, issued a fact check in response to certain media reports about the vaccine. Referring to a report dated December 29th 2021 by Moneycontrol, which stated, “No one can quite say how India’s indigenous Covid-19 vaccine company will meet the challenge of vaccinating close to 10 crore […]
-
Hyderabad: Vaccine maker Bharat Biotech on Wednesday clarified that Paracetamol or pain killers are not recommended for teenagers after being vaccinated with Covaxin. “We have received feedback that certain immunisation centres are recommending taking 3 paracetamol 500 mg tablets along with Covaxin for children. No paracetamol or painkillers are recommended after being vaccinated with Covaxin,” […]
-
New Delhi: The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech’s application for clinical trials of its intranasal Covid vaccine as a booster or a third dose. The Hyderabad-based manufacturer has proposed the booster dose for those who have been […]
-
New Delhi: The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech’s application for clinical trials of its intranasal Covid vaccine as a booster or a third dose. The Hyderabad-based manufacturer has proposed the booster dose for those who have been […]
-
New Delhi: Prime Minister Narendra Modi on Saturday announced that the COVID-19 vaccination for children aged 15-18 years will start from January 3. This comes after Bharat Biotech’s COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, said official sources. In […]
-
Hyderabad: Bharat Biotech has sought the approval of the Drug Controller General of India (DCGI) to conduct Phase 3 trials of its Covid-19 intranasal vaccine, sources said on Monday. The Hyderabad-based vaccine maker has submitted the application and awaiting approval for Phase 3 trials of intranasal vaccine (BBV154). “Intranasal vaccines have the potential to prevent […]
-
Hyderabad: Explaining its 28 days open vial policy, Hyderabad-based Bharat Biotech on Monday stated that healthcare workers do not have to worry about opening Covaxin’s vial and its wastage. This means that an open Covaxin vial can be used up to 28 days post opening and would not go waste if there are no people […]
-
New Delhi: Hyderabad-based Bharat Biotech Chairman Dr Krishna Ella along with Joint Managing Director Suchitra Ella visited the Professor Dr Tran Van Thuan, Deputy Minister of Health, Government of the Socialist Republic of Vietnam, in New Delhi. As per sources, they discussed the Covaxin Covid-19 vaccination to cover children below 18 years in Vietnam. According […]
-
Hyderabad: The Republic of Vietnam will receive two lakh doses of Bharat Biotech’s Covaxin. This donation represents a goodwill gesture to provide access to the company’s WHO approved, indigenously developed Covaxin to fight the Covid-19 pandemic across borders. Covaxin has received emergency use listing in Vietnam. Suchitra Ella, joint managing director of Bharat Biotech, revealed this at […]
-
Hyderabad: Hyderabad-based Covid-19 vaccine (Covaxin) maker Bharat Biotech on Monday said the company has commenced the exports of the vaccine. “Long pending export orders have been executed during November, to be further expanded during the following months. With the number of countries that have granted emergency use approvals for Covaxin increasing, exports to additional countries […]
-
Hyderabad: Covaxin, the first indigenous Covid vaccine developed and manufactured by Hyderabad-based Bharat Biotech, continues to receive recognition from various quarters. The vaccine recently came in for praise from Dr Francis H Collins, Director of National Institutes of Health (NIH), primary agency in the United States for public health research. Following the publishing of interim […]
-
New Delhi: The World Health Organisation (WHO) on Wednesday granted Emergency Use Listing approval to India’s indigenously-developed Covid vaccine, Bharat Biotech’s Covaxin. The global health group’s Technical Advisory Group (TAG) issued the final decision.The WHO, in a tweet, said: “WHO has granted emergency use listing (EUL) to Covaxin, developed by Bharat Biotech, adding to a […]
-
Hyderabad: The shelf life of Hyderabad-based Bharat Biotech’s Covid-19 vaccine, Covaxin, has been extended to 12 months from the present nine months by the Central Drugs Standard Control Organisation (CDSCO). “The CDSCO has approved the extension of shelf life of Covaxin up to 12 months, from the date of manufacture. This approval of shelf life […]
-
Hailing the decision, the Indian High Commission in Guyana said that it is an important step forward in the post Covid partnership between both the countries.
-
Ocugen, the US partner of Bharat Biotech, has submitted an investigational new drug (IND) application with the US Food and Drug Administration (FDA) to evaluate the Covid-19 vaccine candidate, BBV152, known as Covaxin outside the United States. The phase 3 trial proposed in the IND is designed to establish whether the immune response experienced by […]
-
Hyderabad: The state health authorities here have said that are expecting a Covid vaccine for children to be available in the coming two to three weeks. The authorities said that under the guidance of the Ministry of Health and Welfare (MOHFW), extensive ground work is underway in Telangana to start vaccinating children, as and when […]
-
Hyderabad: The World Health Organization (WHO) tweeted on Tuesday that WHO and an independent group of experts will meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing (EUL) to Covaxin. Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling […]
-
MoHFW may approve Covid vaccine this month for those aged between 12 years and 18 years